{"protocolSection":{"identificationModule":{"nctId":"NCT04396418","orgStudyIdInfo":{"id":"STEEER-AF"},"organization":{"fullName":"European Society of Cardiology","class":"NETWORK"},"briefTitle":"Stroke Prevention and Rhythm Control Therapy STEEER-AF","officialTitle":"Stroke Prevention and Rhythm Control Therapy: Evaluation of an Educational Programme of the European Society of Cardiology in a Cluster-Randomised Trial in Patients With Atrial Fibrillation","acronym":"STEEER-AF"},"statusModule":{"statusVerifiedDate":"2020-10","overallStatus":"UNKNOWN","lastKnownStatus":"NOT_YET_RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2021-09-15","type":"ESTIMATED"},"primaryCompletionDateStruct":{"date":"2021-09-15","type":"ESTIMATED"},"completionDateStruct":{"date":"2023-12-31","type":"ESTIMATED"},"studyFirstSubmitDate":"2020-05-14","studyFirstSubmitQcDate":"2020-05-18","studyFirstPostDateStruct":{"date":"2020-05-20","type":"ACTUAL"},"lastUpdateSubmitDate":"2021-08-30","lastUpdatePostDateStruct":{"date":"2021-08-31","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"European Society of Cardiology","class":"NETWORK"},"collaborators":[{"name":"Soladis","class":"UNKNOWN"},{"name":"University of Birmingham","class":"OTHER"}]},"oversightModule":{"oversightHasDmc":true,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"A prospective trial with hospitals/health centres across 6 different European countries, being randomised to either a structured education programme as the intervention or no additional education as the control. To determine whether a comprehensive educational programme for healthcare professionals will increase the rate of appropriate stroke prevention and rhythm control therapy in patients with atrial fibrillation (AF) and adherence to Guidelines.","detailedDescription":"Prospective, parallel group, two-arm, unblinded, international, cluster-randomized controlled trial.\n\nIntervention arm: A 16-week blended learning programme targeting stroke prevention and rhythm control therapy at the healthcare professional level, with controlled assessments, a commitment to change plan, and reinforcement actions Control arm: No added education of healthcare professionals 70 centres with a cluster size of 25 patients; total estimated number of patients 1750.\n\n8-12 weeks patient recruitment period at each centre; 16 weeks educational intervention period; primary \\& secondary outcomes at 6-9 months post-randomisation; remote follow-up for clinical events (no new patient contact) at 18 months from randomisation."},"conditionsModule":{"conditions":["Atrial Fibrillation"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"OTHER","maskingInfo":{"masking":"DOUBLE","whoMasked":["PARTICIPANT","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":1750,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Intervention arm","type":"EXPERIMENTAL","description":"A 16-week blended learning programme targeting stroke prevention and rhythm control therapy at the healthcare professional level, with controlled assessments, a commitment to change plan, and reinforcement actions","interventionNames":["Behavioral: Education"]},{"label":"Control arm","type":"OTHER","description":"No added education of healthcare professionals","interventionNames":["Behavioral: Education"]}],"interventions":[{"type":"BEHAVIORAL","name":"Education","description":"Randomization between two groups at site level. One cluster with education and one without.","armGroupLabels":["Control arm","Intervention arm"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Adherence to ESC Guidelines in Atrial Filbrillation","description":"Full adherence to guidelines for stroke prevention rhythm control therapy","timeFrame":"25 months per centre"}],"secondaryOutcomes":[{"measure":"Proportion of relevant guidelines adhered to","description":"Proportion of relevant guidelines adhered to for stroke prevention and rhythm control","timeFrame":"25 months per centre"}],"otherOutcomes":[{"measure":"Process outcome","description":"Improvement in knowledge and guideline-adherent practice by healthcare professionals using the educational intervention","timeFrame":"25 months per centre"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients diagnosed with AF\n* Patient consents to data collection at baseline and follow-up.\n\nExclusion Criteria (patients only):\n\n* Patients aged under 18 years of age,\n* Pregnant or planning pregnancy,\n* Participating in another clinical trial of an investigational medicinal product or device,\n* Life expectancy of less than 2 years.\n\nPatient assessment: Baseline (time of recruitment) and at follow-up routine appointment (6-9 months), plus remote follow-up at 18 months.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"Céline Arsac","role":"CONTACT","phone":"0033489872075","email":"carsac@escardio.org"},{"name":"Patti-Ann M McNeill","role":"CONTACT","phone":"0033492948637","email":"pmcneill@escardio.org"}],"overallOfficials":[{"name":"Hein Heidbuchel","affiliation":"Universiteit Antwerpen","role":"STUDY_CHAIR"},{"name":"Dipak Kotecha","affiliation":"University of Birmingham","role":"STUDY_DIRECTOR"},{"name":"Isabelle I van Gelder","affiliation":"University Medical Center Groningen, The Netherlands","role":"STUDY_DIRECTOR"},{"name":"Serge Boveda","affiliation":"Clinique Pasteur, France","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Philipp Sommer","affiliation":"Ruhr-Universität Bochum, Germany","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Giuseppe Boriani","affiliation":"University of Modena & Reggio Emilia","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Maciej Sterliński","affiliation":"National Institute of Cardiology, Warsaw, Poland","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Luis Mont","affiliation":"University of Barcelona, Spain","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Kim Rajappan","affiliation":"University of Oxford, UK","role":"PRINCIPAL_INVESTIGATOR"}]},"referencesModule":{"references":[{"pmid":"34969173","type":"DERIVED","citation":"Banerjee A, Pasea L, Chung SC, Direk K, Asselbergs FW, Grobbee DE, Kotecha D, Anker SD, Dyszynski T, Tyl B, Denaxas S, Lumbers RT, Hemingway H. A population-based study of 92 clinically recognized risk factors for heart failure: co-occurrence, prognosis and preventive potential. Eur J Heart Fail. 2022 Mar;24(3):466-480. doi: 10.1002/ejhf.2417. Epub 2022 Jan 26. Erratum In: Eur J Heart Fail. 2022 Sep;24(9):1739."}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000001281","term":"Atrial Fibrillation"}],"ancestors":[{"id":"D000001145","term":"Arrhythmias, Cardiac"},{"id":"D000006331","term":"Heart Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000010335","term":"Pathologic Processes"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M4276","name":"Atrial Fibrillation","asFound":"Atrial Fibrillation","relevance":"HIGH"},{"id":"M4143","name":"Arrhythmias, Cardiac","relevance":"LOW"},{"id":"M9109","name":"Heart Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]}},"hasResults":false}